Karen Vanhoorelbeke

9.6k total citations · 1 hit paper
210 papers, 6.4k citations indexed

About

Karen Vanhoorelbeke is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Karen Vanhoorelbeke has authored 210 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hematology, 119 papers in Immunology and 42 papers in Genetics. Recurrent topics in Karen Vanhoorelbeke's work include Platelet Disorders and Treatments (126 papers), Complement system in diseases (113 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (36 papers). Karen Vanhoorelbeke is often cited by papers focused on Platelet Disorders and Treatments (126 papers), Complement system in diseases (113 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (36 papers). Karen Vanhoorelbeke collaborates with scholars based in Belgium, France and Netherlands. Karen Vanhoorelbeke's co-authors include Hans Deckmyn, Simon F. De Meyer, Hendrik B. Feys, Frederik Denorme, Inge Pareyn, Katleen Broos, Linda Desender, Tommy Andersson, Olivier François and Nele Vandeputte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Karen Vanhoorelbeke

202 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil extracellular traps in ischemic stroke thrombi

2017 374 citations Frederik Denorme, Linda Desender et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Vanhoorelbeke Belgium	41	3.3k	2.8k	1.1k	941	865	210	6.4k
Jing-fei Dong United States	44	3.3k 1.0×	2.0k 0.7×	703 0.6×	1.3k 1.4×	443 0.5×	85	6.9k
Simon F. De Meyer Belgium	41	2.2k 0.7×	2.5k 0.9×	588 0.5×	1.5k 1.6×	1.2k 1.4×	135	6.6k
Ellinor I.B. Peerschke United States	46	2.6k 0.8×	2.6k 0.9×	1.2k 1.0×	1.5k 1.6×	716 0.8×	170	7.6k
Dominic W. Chung United States	47	3.2k 1.0×	2.4k 0.9×	1.6k 1.4×	1.7k 1.9×	437 0.5×	101	8.1k
Peter J. Lenting France	57	5.9k 1.8×	2.2k 0.8×	1.5k 1.3×	1.8k 2.0×	463 0.5×	208	10.0k
Masanori Matsumoto Japan	40	2.6k 0.8×	4.5k 1.6×	1.4k 1.2×	673 0.7×	584 0.7×	308	6.7k
José A. López United States	36	2.9k 0.9×	1.4k 0.5×	489 0.4×	1.2k 1.3×	248 0.3×	111	6.7k
Jan A. van Mourik Netherlands	55	5.7k 1.7×	1.6k 0.6×	1.6k 1.4×	1.9k 2.0×	406 0.5×	172	9.2k
Jerry Ware United States	50	5.2k 1.6×	1.4k 0.5×	801 0.7×	2.0k 2.1×	286 0.3×	148	8.4k
José Sampol France	44	1.3k 0.4×	1.7k 0.6×	405 0.4×	3.5k 3.8×	433 0.5×	92	7.4k

Countries citing papers authored by Karen Vanhoorelbeke

Since Specialization

Citations

This map shows the geographic impact of Karen Vanhoorelbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Vanhoorelbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Vanhoorelbeke more than expected).

Fields of papers citing papers by Karen Vanhoorelbeke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Vanhoorelbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Vanhoorelbeke. The network helps show where Karen Vanhoorelbeke may publish in the future.

Co-authorship network of co-authors of Karen Vanhoorelbeke

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Vanhoorelbeke. A scholar is included among the top collaborators of Karen Vanhoorelbeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Vanhoorelbeke. Karen Vanhoorelbeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pareyn, Inge, Jasper Anckaert, Claudia Tersteeg, et al.. (2025). Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS. Blood Advances. 9(8). 1763–1771. 1 indexed citations

Ma, Min, Jun Qu, Joshua Muia, et al.. (2025). Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity. Arteriosclerosis Thrombosis and Vascular Biology. 45(4). 506–522.

Pareyn, Inge, et al.. (2024). Limited Impact of Drone Transport of Blood on Platelet Activation. Drones. 8(12). 752–752. 1 indexed citations

Sakai, Kazuya, Ilaria Mancini, György Sinkovits, et al.. (2023). Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22(2). 493–502. 7 indexed citations

Sakai, Kazuya, et al.. (2023). ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Journal of Clinical Medicine. 12(19). 6169–6169. 10 indexed citations

Groot, Rens de, Melissa Heightman, Toby Hillman, et al.. (2023). Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. Journal of Thrombosis and Haemostasis. 21(1). 94–100. 14 indexed citations

Noppen, Sam, Dominique Schols, Paul De Munter, et al.. (2023). FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small Methods. 7(3). e2201477–e2201477. 2 indexed citations

Tellier, Edwige, Raphaël Cauchois, Julien Faccini, et al.. (2022). Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity. Haematologica. 108(4). 1127–1140. 8 indexed citations

Callewaert, Nico, Aline Vandenbulcke, Thomas Vercruysse, et al.. (2022). High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium. Viruses. 14(6). 1257–1257. 6 indexed citations

10.

Spasić, Dragana, Hendrik B. Feys, Nick Geukens, et al.. (2021). Tuning the Surface Interactions between Single Cells and an OSTE+ Microwell Array for Enhanced Single Cell Manipulation. ACS Applied Materials & Interfaces. 13(2). 2316–2326. 14 indexed citations

11.

Kangro, Kadri, Kanin Wichapong, Paul Kaijen, et al.. (2021). N-glycan–mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP. Blood. 137(19). 2694–2698. 13 indexed citations

12.

Staessens, Senna, Olivier François, Linda Desender, et al.. (2021). Detailed histological analysis of a thrombectomy-resistant ischemic stroke thrombus: a case report. Thrombosis Journal. 19(1). 11–11. 18 indexed citations

13.

Schelpe, An‐Sofie, Elien Roose, Inge Pareyn, et al.. (2020). Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function. Blood Advances. 4(6). 1072–1080. 30 indexed citations

14.

Peetermans, Marijke, Severien Meyers, Laurens Liesenborghs, et al.. (2019). Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis. Journal of Thrombosis and Haemostasis. 18(3). 722–731. 29 indexed citations

15.

Muia, Joshua, Jian Zhu, Suellen Greco, et al.. (2019). Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation. Blood. 133(17). 1899–1908. 24 indexed citations

16.

Schelpe, An‐Sofie, Christelle Orlando, Inge Pareyn, et al.. (2018). Child‐onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13. European Journal Of Haematology. 101(2). 191–199. 5 indexed citations

17.

Denorme, Frederik, Friederike Langhauser, Linda Desender, et al.. (2016). ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice. Blood. 127(19). 2337–2345. 130 indexed citations

18.

Tersteeg, Claudia, Alexandra Schiviz, Barbara Plaimauer, et al.. (2015). Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats. Journal of Thrombosis and Haemostasis. 13. 152–152. 1 indexed citations

19.

Feys, Hendrik B., Jan Roodt, Nele Vandeputte, et al.. (2012). Inhibition of von Willebrand factor–platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons. Blood. 120(17). 3611–3614. 27 indexed citations

20.

Lecut, Christelle, Anne Schoolmeester, Marijke J. E. Kuijpers, et al.. (2004). Principal Role of Glycoprotein VI in α2β1 and αIIbβ3 Activation During Collagen-Induced Thrombus Formation. Arteriosclerosis Thrombosis and Vascular Biology. 24(9). 1727–1733. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact